Abstract
Introduction

32
Next generation sequencing (NGS) is rapidly becoming established in the clinic, predominantly 33 in oncology but also as a means of diagnosis in individuals with unresolved medical issues.
34
Archival tissue represents a singularly valuable resource for disease oriented research,
35
particularly when combined with comprehensive medical records such as that of the Mayo 36 Clinic. However, DNA extracted from such samples can vary widely in quality due to age, 37 fixation conditions, DNA-protein crosslinking, and inhibitors, which may impact downstream 38 genomic analyses. Samples are typically obtained in the operating room so how they are 39 handled, as well as time exposed to formalin both contribute to potential DNA damage but are 40 typically outside the control of investigators [1] .
41
With the use of highly sensitive NGS applications it is imperative that the FFPE DNA 42 extractions used in these assays be of the best quality obtainable. 
66
These samples were selected to represent a spectrum of quality, from highly cellular to those 67 with high adipose tissue content that typically yield poorer quality DNA. After DNA quality and 68 quantity were assessed, four of the processes were chosen to be evaluated for performance in 69 NGS technologies. These included two library preparation protocols for low input DNA whole 70 exome sequencing (WES), as limited DNA yields from FFPE samples are common, and two 71 targeted DNA panels. 
72
Material and Methods
73
Samples
126
Analysis Bioinformatics analysis for the WES was performed using in-house DNA analysis workflow 128 (GenomeGPS v4.0.1). The reads were first aligned to the GRCh37 build of the human reference 129 genome using BWA-MEM with the default parameter settings. After alignment, the reads were 130 re-aligned and re-calibrated using Genome Analysis Toolkit (GATK) Indel Realigner to optimize 131 the mapping around indels. Variant calling was then performed on the realigned reads using 132 GATK Haplotype Caller and the called variants were functionally annotated using an in-house 133 developed genomics annotation tool BioR. The QIAseq panel analysis was performed using 134 QIAGEN's NGS data analysis portal. The portal performs appropriate read trimming, generating 135 consensus reads using unique molecular indexes (UMIs), and variant calling using QIAGEN's 136 barcode-aware variant caller "smCounter", followed by variant annotation. We used a cutoff of 137 5x for concordance analyses.
138
Results
139
DNA Extraction
140
The methods used to extract DNA from the 12 FFPE samples are shown in Table 1 along with 141 the acronym used for each in this report; modifications were not added to the manufacturers' 142 protocols with one exception noted above. 
226
While we did not observe significant differences in duplication rates between the four DNA 227 extraction methods (∆ duplication = 3.05 percent), we observed that the read duplication rates were 228 lower with the Ultra II library preparation method (11.9 percent) than ThruPlex (26.21 percent).
229
Also, for the most degraded sample, cerebellum, duplication rates were generally higher than 230 for the other tissues types (S4). 
263
The distribution of coverage for the comprehensive cancer panel for three representative 264 samples is shown in (Fig 4. ) Each of the four methods yielded some proportion of target bases 265 even at a raw coverage value as high as 5000X but the proportion of targeted bases covered 266 above 5000X drops off significantly. For the highly degraded cerebellum sample, the raw 267 coverage drops off beyond 2500X. Figure 4B represents the raw coverage of a subset of 268 targeted regions across the four methods. 306 DNA from four extraction methods (manual and automated) were assayed for low input WES 307 and amplicon based targeted sequencing based on yield, percent dsDNA and fragment length.
308
For WES, the NEBNext Ultra II low input library preparation provided the lower duplicated reads, 309 better coverage, and higher reads in capture regions than did those prepared using ThruPlex for 310 the four extraction methods. The very fragmented DNA from cerebellum had lower reads in 311 capture region and higher duplication rates for WES but was effectively profiled using an 312 amplicon-based targeted approach.
313
The low input library preparation methods were very similar, the only difference being the type 314 of bead used for the cleanup step, suggesting that small changes can impact downstream 315 performance. There are new methods emerging for use of small inputs for NGS applications, 316 which should further broaden the number of samples available for use.
317
There are some challenges using FFPE DNA in NGS. There were no substantial differences in 318 sequencing results for the four selected protocols, neither was there any difference in the 319 spectrum of variation found. The FFPE signature, of C>T transitions was similar in all tested 320 methods. As in Spencer et al [18] , the finding that C>T transitions often occurred in CpG dyads 321 supports the observation that deamination of cytosine FFPE is a major source of artefactual 322 variations in FFPE DNA [1] . This occurs in living cells and uracil-DNA glycosylase (UDG) 323 removes the altered base; the abasic site is then restored to cytosine by base excision repair [1] .
324
The GeneRead protocol includes a repair step (UDG) which ameliorates, but does not totally 325 eliminate, these artefacts. Bioinformatics approaches to dealing with these artefacts will 326 enhance the use of FFPE derived DNA in epidemiologic studies.
327
The strengths of this report are the evaluation of nine DNA extraction methods, including 328 manual and automated, and evaluation of low input library preparation protocols. Sequential 329 sections from a single block for each sample were used, to best assess each extraction 330 approach. As the samples included in the study were anonymized, it was not possible to Table 1 Percentage of fragments within each size range for all DNA extraction methods 336 for the 12 samples.
337
S3 Table 2
Multiplex PCR data expressed as percentage compared to a CEPH control.
338
Highlighted columns represent those methods selected for evaluation in NGS. 
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